[108. Effective heart ischemia duration in relation to the energy starting position of the myocardium, the form of cardioplegia and the temperature].
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D004285:Dogs; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000378:metabolism; D006324:Heart Arrest, Induced; D006801:Humans; D007036:Hypothermia, Induced; D066298:In Vitro Techniques; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism; D010735:Phosphoglycerate Kinase / Q000378:metabolism; D013771:Tetralogy of Fallot / Q000601:surgery; D013997:Time Factors
D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D005954:Glucosephosphate Dehydrogenase; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D010735:Phosphoglycerate Kinase
108. Nutzbare Ischämiedauer des Herzens in Abhängigkeit von der energetischen Ausgangslage des Myokards, der Kardioplegieform und der Temperatur.